Abstract: The invention relates to a composition for use in reducing hair loss and/or increasing regrowth of hair in a human subject comprising minoxidil, either a 5?-reductase inhibitor or an androgen receptor antagonist, and a prostaglandin analog. In one embodiment, the composition comprises minoxidil, a 5?-reductase inhibitor, and a prostaglandin analog, wherein the 5?-reductase inhibitor is finasteride. In another embodiment, the prostaglandin analog is latanoprost. In yet another embodiment, the composition is for topical application to a scalp. The invention also relates to the use of such a composition to reduce hair loss and/or increase regrowth of hair in a human subject.
Abstract: The invention relates to formulations comprising 2% to 10% minoxidil, 0.01% to 15% of a prostaglandin analogue, and, optionally 0.01% to 15% finasteride, and to formulations comprising 0.1 to 60% Dapsone and/or 0.1 to 20% Minocycline, tetracycline or doxycycline as an active ingredient. In one embodiment, the prostaglandin analogue is latanoprost. In a preferred embodiment, the composition comprises 5% minoxidil and 0.03% latanoprost. In another preferred embodiment, the composition further comprises 0.1% finasteride. The invention also relates to the use of the formulations to reduce hair loss and/or increase regrowth of hair in a human subject.
Abstract: The invention relates to a composition comprising 2% to 5% minoxidil, 0.01% to 15% of a 5?-reductase inhibitor or an androgen receptor antagonist, and 0.01% to 15% of a prostaglandin analogue. In one embodiment, the prostaglandin analogue is latanoprost. In a preferred embodiment, the composition comprises 5% minoxidil, 0.1% finasteride and 0.03% latanoprost. The invention also relates to the use of the said composition to reduce hair loss and/or increase regrowth of hair in a human subject.
Abstract: The invention relates to a composition comprising 2% to 5% minoxidil, 0.01% to 15% finasteride and 0.01% to 15% of a prostaglandin analog. In one embodiment, the prostaglandin analog is latanoprost. I a preferred embodiment, the composition comprises 5% minoxidil, 0.1% finasteride and 0.03% latanoprost. The invention also relates to the use of the said composition to reduce hair loss and/or increase regrowth of hair in a human subject.
Abstract: The invention relates to a composition comprising 0.01% to 15% resveratrol and 0.01% to 15% of melatonin. In a preferred embodiment, the composition comprises 5% resveratrol and 0.1% melatonin. The invention also relates to the use of the said composition to reduce hair loss and/or increase regrowth of hair in a human subject.
Abstract: The invention relates to a composition comprising 2% to 5% minoxidil, 0.01% to 15% of a 5?-reductase inhibitor or an androgen receptor antagonist, and 0.01% to 15% of a prostaglandin analogue. In one embodiment, the prostaglandin analogue is latanoprost. In a preferred embodiment, the composition comprises 5% minoxidil, 0.1% finasteride and 0.03% latanoprost. The invention also relates to the use of the said composition to reduce hair loss and/or increase regrowth of hair in a human subject.
Abstract: The invention relates to a composition comprising 2% to 5% minoxidil, 0.01% to 15% finasteride and 0.01% to 15% of a prostaglandin analogue. In one embodiment, the prostaglandin analogue is latanoprost. I a preferred embodiment, the composition comprises 5% minoxidil, 0.1% finasteride and 0.03% latanoprost. The invention also relates to the use of the said composition to reduce hair loss and/or increase regrowth of hair in a human subject.